Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum. R93.5 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM R93.5 became effective on October 1, 2018.
Full Answer
R93.81 ICD-10-CM Code for Abnormal findings on diagnostic imaging of other specified body structures R93.8
NOTE: For institutional claims, continue to include ICD-9 diagnosis code V70.7 or ICD-10 diagnosis code Z00.6 and condition code 30 to denote a clinical study. PET claims billed to inform initial treatment strategy with the following Procedure codes AND modifier –PI: 78608, 78811, 78812, 78813, 78814, 78815, 78816.
Procedure guidance is clear in the Procedure parenthetical following the PET tumor codes: “report 78811-78816 only once per imaging session”. Therefore, providers may use one Procedure code in the series 78811-78816 when billing PET tumor imaging.
If this is a Medicare patient and your imaging facility does NOT participate in NOPR, use code G0235 (PET imaging, any site, not otherwise specified ) for Medicare non-covered PET services. If this is a third party other than Medicare check with the payer, for the correct coding could be either Procedure 78608- 59 or the G0235 code.)
R93.88 for Abnormal findings on diagnostic imaging of other specified body structures is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
Other abnormal findings in specimens from other organs, systems and tissues. R89. 8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R89.
Other nonspecific abnormal finding of lung field The 2022 edition of ICD-10-CM R91. 8 became effective on October 1, 2021.
ICD-10 code: R93. 8 Abnormal findings on diagnostic imaging of other specified body structures.
A Report a code for the preventive service with an abnormal finding only when the finding is a new problem identified at this encounter or when there is increased severity or inadequate control of an existing problem.
Per Coding Clinic First Quarter 2016 “For the purpose of assigning codes from this category, an “abnormal finding” is a newly discovered condition, or a known/chronic condition that has increased in severity.” When documentation supports an additional condition is being addressed during a general examination encounter, ...
R93.89 - Abnormal findings on diagnostic imaging of other specified body structures.
Computerized Tomography (CT Scan) of Chest, Abdomen and Pelvis using Other Contrast BW25YZZ. ICD-10-PCS code BW25YZZ for Computerized Tomography (CT Scan) of Chest, Abdomen and Pelvis using Other Contrast is a medical classification as listed by CMS under Anatomical Regions range.
ICD-10-CM Code for Solitary pulmonary nodule R91. 1.
ICD-10 code E04. 1 for Nontoxic single thyroid nodule is a medical classification as listed by WHO under the range - Endocrine, nutritional and metabolic diseases .
ICD-10-CM Code for Elevation of levels of liver transaminase levels R74. 01.
N85. 00 - Endometrial hyperplasia, unspecified | ICD-10-CM.
CPT codes, descriptions and other data only are copyright 2020 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.
CMS IOM Publication 100-03, Medicare National Coverage Determinations Manual , Chapter 1, Part 4, Section 220.6.17 - Positron Emission Tomography (FDG PET) for Oncologic Conditions
Notice: It is not appropriate to bill Medicare for services that are not covered (as described by the entire NCD) as if they are covered. When billing for non-covered services, use the appropriate modifier.
It is the provider's responsibility to select codes carried out to the highest level of specificity and selected from the ICD-10-CM code book appropriate to the year in which the service is rendered for the claim (s) submitted.
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the article does not apply to that Bill Type.
Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory. Unless specified in the article, services reported under other Revenue Codes are equally subject to this coverage determination.
CPT codes, descriptions and other data only are copyright 2020 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.
This article describes the least restrictive coverage possible. Providers must read the entire NCD and related Internet Only Manual (IOM) sections (see "Sources" at end of this article) in order to correctly understand and apply the following coding guidance.
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the article does not apply to that Bill Type.
Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory. Unless specified in the article, services reported under other Revenue Codes are equally subject to this coverage determination.
The Medicare Advantage Policy Guideline documents are generally used to support UnitedHealthcare Medicare Advantage claims processing activities and facilitate providers’ submission of accurate claims for the specified services. The document can be used as a guide to help determine applicable:
Positron Emission Tomography (PET) is a minimally invasive diagnostic imaging procedure used to evaluate metabolism in normal tissue as well as in diseased tissues in conditions such as cancer, ischemic heart disease, and some neurologic disorders. A radiopharmaceutical is injected into the patient that gives off sub-atomic particles, known as positrons, as it decays. PET uses a positron camera (tomography) to measure the decay of the radiopharmaceutical. The rate of decay provides biochemical information on the metabolism of the tissue being studied.
Note: Manual section 220.6 lists all Medicare-covered uses of PET scans. Except as set forth below in cancer indications listed as “Coverage with Evidence Development,” a particular use of PET scans is not covered unless this manual specifically provides that such use is covered. Although PET scan sections may have some non-covered uses, it does not constitute an exhaustive list of all non-covered uses.
1. FDG PET Requirements for Coverage in the Differential Diagnosis of AD and FTD An FDG PET scan is considered reasonable and necessary in patients with a recent diagnosis of dementia and documented cognitive decline of at least 6 months , who meet diagnostic criteria for both AD and FTD. These patients have been evaluated for specific alternate neurodegenerative diseases or other causative factors, but the cause of the clinical symptoms remains uncertain. The following additional conditions must be met before an FDG PET scan will be covered:
Insertion of a PET is indicated for continuous middle ear aeration in patients with chronic otitis media with effusion (OME). It is estimated that some 27 million cases of otitis media occur each year and that 1,000,000 children undergo PET insertion each year, making this procedure the most frequently performed pediatric surgery requiring anesthesia. Nevertheless, since conventional PET requires general anesthesia, it is typically not considered unless multiple courses of antibiotics fail to clear the infection and resolve the effusion. Myringotomy alone is less frequently performed. Since a conventional incision typically closes up within 1 or 2 days it cannot be used for prolonged ventilation of the middle ear. Myringotomies can be used to acutely decompress the ear and thus relieve pain. In addition, aspiration of fluid can be used for diagnostic purposes to determine whether the fluid is sterile and, if not, to assess antibiotic sensitivities.
Claims for PET scan services must be billed using the ASC X12 837 professional claim format or on Form-CMS 1500 with the appropriate HCPCS or CPT code and diagnosis codes to the A/B MAC (B). Effective for claims received on or after July 1, 2001, PET modifiers were discontinued and are no longer a claims processing requirement for PET scan claims. Therefore, July 1, 2001, and after the MSN messages regarding the use of PET modifiers can be discontinued. The type of service (TOS) for the new PET scan procedure codes is TOS 4, Diagnostic Radiology. Payment is based on the Medicare Physician Fee Schedule.
PET uses a positron camera (tomography) to measure the decay of the radiopharmaceutical. The rate of decay provides biochemical information on the metabolism of the tissue being studied.
Positron Emission Tomography (PET) is a minimally invasive diagnostic imaging procedure used to evaluate metabolism in normal tissue as well as in diseased tissues in conditions such as cancer, ischemic heart disease, and some neurologic disorders. A radiopharmaceutical is injected into the patient that gives off sub-atomic particles, known as positrons, as it decays. PET uses a positron camera (tomography) to measure the decay of the radiopharmaceutical. The rate of decay provides biochemical information on the metabolism of the tissue being studied.
The limited study is considered part of the whole body study. In general, when the AMA RUC (RUC stands for Relative Update Committee) values Procedure codes, it does so on the basis of a typical study (including additional views). Providers should choose the appropriate code to reflect the body area imaged.
The answer is both no and yes. Procedure guidance is clear in the Procedure parenthetical following the PET tumor codes: “report 78811-78816 only once per imaging session”. Therefore, providers may use one Procedure code in the series 78811-78816 when billing PET tumor imaging.